期刊文献+

先天性肾上腺皮质增生症新生儿筛查 被引量:18

Newborn screening for congenital adrenal hyperplasia
原文传递
导出
摘要 先天性肾上腺皮质增生症(congenital adrenal hyperplasia,CAH)最常见原因是21-羟化酶缺乏(21-hydroxylase deficiency,21-OHD)。新生儿CAH筛查是指通过测定干滤纸血片中17-羟孕酮浓度,进行21-OHD的筛查。总结新生儿CAH筛查国内外现状、筛查方法、确诊方法及治疗原则,可为相关实验人员及临床医生筛查的规范化提供帮助。 Congenital adrenal hyperplasia (CAH)is mainly caused by 21-hydroxylase deficiency (21-OHD). Nationwide neonatal screening for CAH caused by 21-OHD in China isbased on measurement of 17-hydroxyprogesterone (17-OHP) levels from heel-stick blood samples on filter paper. The situa- tion and methods of neonatal screening, confirmed diagnosis and therapeutic rule for CAH in China and other countries are described for the standardization of screening.
作者 叶军
出处 《中国实用儿科杂志》 CSCD 北大核心 2016年第6期422-425,共4页 Chinese Journal of Practical Pediatrics
关键词 先天性肾上腺皮质增生症 21-羟化酶缺乏 生儿筛查 17-羟孕酮 congenital adrenal hyperplasia 21- hydroxylasedeficiency neonatal screening 17-hydroxyprogesterone
  • 相关文献

参考文献16

  • 1顾学范主编..临床遗传代谢病[M].北京:人民卫生出版社,2015:456.
  • 2Merke DP, Bomstein SR. Congenital adrenal hyperplasia [J]. Lancet,2005,365(6) : 2125-2136. 被引量:1
  • 3Tarini BA. The value of time in assessing the effectiveness of newborn screening for congenital adrenal hyperplasia [J ]. JAMA Pediatr,2014,168(3) :515-516. 被引量:1
  • 4Sharma R, Seth A. Congenital adrenal hyperplasia : issues in di- agnosis and treatment in children [J]. Indian J Pediatr, 2014, 81(2): 178-185. 被引量:1
  • 5Speiser PW, Azziz R, Baskin LS, et al. Congenital adrenal hyper- plasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline [J]. J Clin Endocrnol Metab, 2010,95(9) : 4133-4160. 被引量:1
  • 6Gidlof S, Wedell A, Guthenberg C, et al. Nationwide neonatal screening for congenital adrenal hyperplasia in Sweden a 26- Year longitudinal prospective population-based study [J]. JA- MA Pediatr, 2014,168: 567-574. 被引量:1
  • 7Chan CL; McFann K, Taylor L, et al. Congenital adrenal hyper- plasia and the second newborn screen [J]. J Pediatr,2013,163 (1):109-113. 被引量:1
  • 8Sarafoglou K, Banks K, Gaviglio A, et al. Comparison of one- tier and two-tier newborn screening metrics for congenital adre- nal hyperplasia[J]. J Pediatr,2012,130(5) : 1261- 1268. 被引量:1
  • 9White PC. Optimizing newborn screening for congenital adrenal hyperplasia [J]. J Pediatr,2013,163( 1 ) : 10-12. 被引量:1
  • 10van der Kamp HJ, Oudshoom CG, Elvers BH, et al. Cutoff lev- els of 17-alpha-hydroxyprogesterone in neonatal screening for congenital adrenal hyperplasia should be based on gestational age rather than on birth weight [J]. J Clin Endocrnol Metab. 2005,90(7) : 3904-3907. 被引量:1

同被引文献111

引证文献18

二级引证文献74

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部